CLOSED
Lenskart Solutions Limited, a technology-driven eyewear company, engages in designing, manufacturing, branding, and retailing of eyewear products in India, Japan, Southeast Asia, and the Middle East. The company's products include prescription eyeglasses, sunglasses, goggles, screen glasses, and other products, such as contact lenses and eyewear accessories, including frames for men, women, and kids. It engages in lens manufacturing, lens edging, lens design, frame design, frame manufacturing, and delivery. The company operates as a direct-to-consumer company that designs and sells a wide rang. Track LENSKART SOLUTIONS LTD's live NSE:LENSKART share price ₹566.30 (+0.94%), market cap ₹₹981B, P/E 193.9. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for LENSKART — real-time NSE India stock intelligence.
Open
₹566.00
High
₹574.55
Low
₹559.30
Prev. Close
₹561.00
52W High
₹575.70
52W Low
₹356.10
Lenskart Solutions Limited, a technology-driven eyewear company, engages in designing, manufacturing, branding, and retailing of eyewear products in India, Japan, Southeast Asia, and the Middle East. The company's products include prescription eyeglasses, sunglasses, goggles, screen glasses, and other products, such as contact lenses and eyewear accessories, including frames for men, women, and kids. It engages in lens manufacturing, lens edging, lens design, frame design, frame manufacturing, and delivery. The company operates as a direct-to-consumer company that designs and sells a wide rang
Key Takeaway
LENSKART SOLUTIONS LTD is rated buy with a P/E of 193.9x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is LENSKART SOLUTIONS LTD fairly valued right now?
Because a P/E of 193.9x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting LENSKART SOLUTIONS LTD
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
2,516 Cr
Revenue
200 Cr
Net Profit
6.7%
ROE
0%
ROCE
2.92
EPS
| ₹ in Crore | FY25 | FY26 | TTM |
|---|---|---|---|
| Revenue | 6,493 | 8,790 | 8,221 |
| Net Profit | 296 | 494 | 552 |
| ROE (%) | — | 6.7% | 6.7% |
| EPS (₹) | — | 2.92 | 2.92 |
| Debt/Equity | — | 35.0 | 35.0 |